Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Neurology

The FTD Spectrum: Understanding the Variants and Subtypes

At a Glance

Frontotemporal dementia (FTD) is a spectrum of related disorders, not a single disease. The main subtypes include the behavioral variant (bvFTD), language variants (PPA), and motor disorders. Symptoms often overlap and evolve as the disease spreads to different areas of the brain.

Frontotemporal dementia (FTD) is not a single disease, but a clinical spectrum [1]. This means that while different variants of FTD may start in different parts of the brain with distinct symptoms, they are all part of the same family and often overlap as the disease progresses [2][3]. Understanding where your loved one sits on this spectrum can help you anticipate their needs and build a more effective care team.

The Behavioral and Language Variants

The most common forms of FTD are categorized by whether they first affect a person’s behavior or their ability to communicate.

  • Behavioral Variant (bvFTD): This is the most common subtype. It primarily targets the brain’s frontal lobes, which control “executive functions” like judgment and social behavior [4][5]. Early signs often include apathy (loss of interest), disinhibition (loss of social filters), and a lack of empathy [6][7].
  • Primary Progressive Aphasia (PPA): In these variants, the primary symptom for the first few years is a decline in language [8].
    • Semantic Variant (svPPA): People with svPPA slowly lose the “meaning” of words. They may struggle to name common objects (like a “pen” or “fork”) or understand the definition of simple words [1][9].
    • Nonfluent/Agrammatic Variant (nfvPPA): This variant makes the physical act of speaking difficult and “effortful.” Speech may become slow, choppy, or grammatically simplified (e.g., leaving out words like “the” or “is”) [9][10].
    • Logopenic Variant (lvPPA): Causes difficulty finding words and repeating sentences. Unlike other forms of PPA, this variant is most often driven by underlying Alzheimer’s disease pathology rather than frontotemporal lobar degeneration [11][12].

The Movement Spectrum

In some cases, FTD overlaps with disorders that affect the body’s motor system. These are often called FTD-related disorders [13][14].

  • FTD-ALS: About 10-15% of people with FTD also develop Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease). This combination causes both cognitive/behavioral changes and physical muscle weakness or twitching [15][16].
  • Progressive Supranuclear Palsy (PSP): This variant often presents with early balance problems, frequent falls, and difficulty controlling eye movements [17][18].
  • Corticobasal Syndrome (CBS): CBS typically causes extreme stiffness or clumsiness in one limb (the “alien limb” sensation), along with difficulty performing coordinated tasks [1][19].

A Multidimensional Journey

It is important to remember that FTD is “phenotypically heterogeneous,” meaning it looks different in everyone [3]. While your loved one may start with only language struggles (PPA), it is common for behavioral symptoms to emerge later as the disease spreads to other brain regions [20][21]. Similarly, a person with bvFTD may eventually develop movement or language difficulties [22][1].

Doctors use tools like the Clinical Dementia Rating (CDR) plus NACC FTLD to track these shifts across different “domains” like behavior and language [23][24]. Recognizing that these symptoms are part of a shifting spectrum—rather than separate, unrelated problems—can help you and your doctors provide more cohesive care [25].

Variant Group Primary Starting Point Key Early Features
Behavioral Personality & Social Filters Disinhibition, apathy, loss of empathy [7]
Language (PPA) Communication & Words Word-finding issues, loss of word meaning [8]
Motor/Movement Physical Coordination Stiffness, falls, muscle weakness [13]

Common questions in this guide

What is the most common variant of frontotemporal dementia?
The behavioral variant (bvFTD) is the most common subtype. It primarily affects the brain's frontal lobes, leading to early changes in personality, social behavior, and empathy.
Do frontotemporal dementia symptoms change or overlap over time?
Yes, FTD is a spectrum disorder, meaning symptoms frequently overlap as the disease progresses. A person who begins with isolated language difficulties may eventually develop behavioral changes or movement issues.
How does FTD affect a person's language skills?
FTD can cause Primary Progressive Aphasia (PPA), a group of variants that specifically target communication skills. Depending on the exact subtype, this can lead to difficulties finding the right words, understanding word meanings, or speaking clearly.
Can frontotemporal dementia cause physical movement problems?
Yes, some people with FTD develop related motor disorders such as FTD-ALS, Progressive Supranuclear Palsy (PSP), or Corticobasal Syndrome (CBS). These conditions can cause physical symptoms including muscle weakness, severe stiffness, frequent falls, and balance problems.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given the symptoms we are seeing, which specific variant on the FTD spectrum (bvFTD, svPPA, or nfvPPA) is the most likely primary diagnosis?
  2. 2.Are there signs of motor involvement, such as muscle weakness or stiffness, that might suggest an overlap with ALS, PSP, or CBS?
  3. 3.How do you expect my loved one's symptoms to 'migrate' or overlap as the disease progresses—for example, will a language variant eventually develop behavioral symptoms?
  4. 4.Should we include a speech-language pathologist or a physical therapist on our care team to address specific communication or movement challenges?
  5. 5.What neuroimaging or biomarker tests (like NfL) can help differentiate between these variants or track their progression?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (25)
  1. 1

    Neuropsychiatric Aspects of Frontotemporal Dementia.

    Younes K, Miller BL

    The Psychiatric clinics of North America 2020; (43(2)):345-360 doi:10.1016/j.psc.2020.02.005.

    PMID: 32439026
  2. 2

    Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations.

    Lashley T, Rohrer JD, Mead S, Revesz T

    Neuropathology and applied neurobiology 2015; (41(7)):858-81 doi:10.1111/nan.12250.

    PMID: 26041104
  3. 3

    Association of cortical morphology, white matter hyperintensity, and glymphatic function in frontotemporal dementia variants.

    Xiao D, Li J, Ren Z, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2024; (20(9)):6045-6059 doi:10.1002/alz.14158.

    PMID: 39129270
  4. 4

    Identifying and Addressing Functional Communication Challenges in Patients With Behavioral Variant Frontotemporal Dementia.

    Meade G, Machulda MM, Clark HM, et al.

    American journal of speech-language pathology 2024; (33(4)):1573-1589 doi:10.1044/2024_AJSLP-24-00013.

    PMID: 38843453
  5. 5

    Social Cognition in Behavioral Variant Frontotemporal Dementia and Pathological Subtypes: A Narrative Review.

    Dilcher R, Malpas CB, O'Brien TJ, Vivash L

    Journal of Alzheimer's disease : JAD 2023; (94(1)):19-38 doi:10.3233/JAD-221171.

    PMID: 37212100
  6. 6

    Diminished preparatory physiological responses in frontotemporal lobar degeneration syndromes.

    Chen KH, Hua AY, Toller G, et al.

    Brain communications 2022; (4(2)):fcac075 doi:10.1093/braincomms/fcac075.

    PMID: 35441132
  7. 7

    Diagnosing, monitoring and managing behavioural variant frontotemporal dementia.

    Piguet O, Kumfor F, Hodges J

    The Medical journal of Australia 2017; (207(7)):303-308 doi:10.5694/mja16.01458.

    PMID: 28954617
  8. 8

    Genetic screen in a large series of patients with primary progressive aphasia.

    Ramos EM, Dokuru DR, Van Berlo V, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2019; (15(4)):553-560 doi:10.1016/j.jalz.2018.10.009.

    PMID: 30599136
  9. 9

    Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology.

    Peet BT, Spina S, Mundada N, La Joie R

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; (18(2)):728-752 doi:10.1007/s13311-021-01101-x.

    PMID: 34389969
  10. 10

    A longitudinal study of speech production in primary progressive aphasia and behavioral variant frontotemporal dementia.

    Ash S, Nevler N, Phillips J, et al.

    Brain and language 2019; (194()):46-57 doi:10.1016/j.bandl.2019.04.006.

    PMID: 31075725
  11. 11

    Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features.

    Rogalski E, Sridhar J, Rader B, et al.

    Neurology 2016; (87(13)):1337-43 doi:10.1212/WNL.0000000000003165.

    PMID: 27566743
  12. 12

    Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.

    Bergeron D, Gorno-Tempini ML, Rabinovici GD, et al.

    Annals of neurology 2018; (84(5)):729-740 doi:10.1002/ana.25333.

    PMID: 30255971
  13. 13

    Atypical parkinsonian syndromes: a general neurologist's perspective.

    Deutschländer AB, Ross OA, Dickson DW, Wszolek ZK

    European journal of neurology 2018; (25(1)):41-58 doi:10.1111/ene.13412.

    PMID: 28803444
  14. 14

    Decoding TDP-43: the molecular chameleon of neurodegenerative diseases.

    Zeng J, Luo C, Jiang Y, et al.

    Acta neuropathologica communications 2024; (12(1)):205 doi:10.1186/s40478-024-01914-9.

    PMID: 39736783
  15. 15

    Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis.

    Cajanus A, Katisko K, Kontkanen A, et al.

    Annals of clinical and translational neurology 2020; (7(6)):903-910 doi:10.1002/acn3.51041.

    PMID: 32441885
  16. 16

    Frontotemporal Dysfunction and Dementia in Amyotrophic Lateral Sclerosis.

    Woolley SC, Strong MJ

    Neurologic clinics 2015; (33(4)):787-805.

    PMID: 26515622
  17. 17

    Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.

    Jabbari E, Holland N, Chelban V, et al.

    JAMA neurology 2020; (77(3)):377-387 doi:10.1001/jamaneurol.2019.4347.

    PMID: 31860007
  18. 18

    Frontotemporal Lobar degeneration with TDP-43 presenting as progressive supranuclear palsy syndrome.

    Murakami A, Koga S, Sekiya H, et al.

    Acta neuropathologica communications 2025; (13(1)):151 doi:10.1186/s40478-025-02058-0.

    PMID: 40635087
  19. 19

    Progressive Supranuclear Palsy and Corticobasal Syndrome.

    McFarland NR

    Continuum (Minneapolis, Minn.) 2025; (31(4)):1023-1049 doi:10.1212/cont.0000000000001607.

    PMID: 40748119
  20. 20

    The natural history of primary progressive aphasia: beyond aphasia.

    Ulugut H, Stek S, Wagemans LEE, et al.

    Journal of neurology 2022; (269(3)):1375-1385 doi:10.1007/s00415-021-10689-1.

    PMID: 34216263
  21. 21

    More than words: Social cognition across variants of primary progressive aphasia.

    Fittipaldi S, Ibanez A, Baez S, et al.

    Neuroscience and biobehavioral reviews 2019; (100()):263-284 doi:10.1016/j.neubiorev.2019.02.020.

    PMID: 30876954
  22. 22

    Progress in Primary Progressive Aphasia: A Review.

    Kertesz A, Finger E, Munoz DG

    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2024; (37(1)):3-12 doi:10.1097/WNN.0000000000000365.

    PMID: 38498721
  23. 23

    Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.

    Miyagawa T, Brushaber D, Syrjanen J, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2020; (16(1)):106-117 doi:10.1002/alz.12033.

    PMID: 31914218
  24. 24

    Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium.

    Miyagawa T, Brushaber D, Syrjanen J, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2020; (16(1)):79-90 doi:10.1016/j.jalz.2019.05.013.

    PMID: 31477517
  25. 25

    Predictors of survival in frontotemporal lobar degeneration syndromes.

    El-Wahsh S, Finger EC, Piguet O, et al.

    Journal of neurology, neurosurgery, and psychiatry 2021; doi:10.1136/jnnp-2020-324349.

    PMID: 33441385

This page provides educational information about frontotemporal dementia variants and the FTD spectrum. It is not a substitute for professional medical advice or a formal evaluation by a neurologist.

Get notified when new evidence is published on Frontotemporal dementia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.